Kerk et al19 and Garcia-Bermudez et al21 found that proliferation of pancreatic cancer cells in vitro is dependent on GOT2, but that GOT2 is not required for tumor growth in immunodeficient or immunocompetent mouse xenograft models of pancreatic cancer. Here, GOT2 is linked to pancreatic neoplasm.